{"id":"a6d5909a-f77e-428b-ab11-addb5447c2aa","kind":"institutions","code":"UB-I5926","name":"Haijinge Pharmaceutical","nameBasis":"transliterated","summary":"Haijinge Pharmaceutical, an investor using its parent company’s industry resources and corporate capital to invest in early-stage ventures.","description":"Haijinge Pharmaceutical, an investor using its parent company’s industry resources and corporate capital to invest in early-stage ventures.","country":null,"category":null,"originalName":"海金格医药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:44:21.863Z","englishUpdatedAt":"2026-10-15T17:35:39.539Z","reviewedAt":"2026-10-15T17:35:39.539Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ec5fd16fcdc93838b75c80ab49d3a5001142c961c8225d64cb2a012d94726c7a","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"海金格医药，依托母公司产业资源，以产业资本投资早期创业项目。","sources":[],"related":[{"id":"3d5c8a2a-7746-46ea-adaf-535bc0ef27ae","kind":"news","code":"3d5c8a2a-7746-46ea-adaf-535bc0ef27ae","name":"Phil Rivers raises RMB 100 million in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"哲源科技完成1亿人民币A轮融资","eventDate":"2022-06-15T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:38:22.624Z","englishUpdatedAt":"2026-10-15T17:19:59.417Z","reviewedAt":"2026-10-15T17:19:59.417Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"194e86a2847d916a92d0da9a0ad34d3ae7b1282522683af4ca1b00c9bddea053","companyId":"379cea5b-ef8c-4bca-a8e9-dac76fb4710d","foundedYear":null,"logoUrl":null,"path":"/news/3d5c8a2a-7746-46ea-adaf-535bc0ef27ae"}],"path":"/institutions/haijinge-pharmaceutical","displayName":"海金格医药","displayNameLang":"zh","structured":{"city":null,"country":"China (mainland)","location":null,"role":null,"category":null,"company":null},"definition":"海金格医药 is a corporate venture capital investor based in China (mainland) with 1 recorded investment.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/institutions/haijinge-pharmaceutical"}